Digenic inheritance of severe insulin resistance in a human pedigree

Nature Genetics

Volumn 31, Issue 4, 2002, Pages 379-384

  Savage, David B ^a,b   Agostini, Maura ^b   Barroso, Inês ^c   Gurnell, Mark ^b   Luan, Jian’an ^a   Meirhaeghe, Aline ^a,b   Harding, Anne Helen ^a   Ihrke, Gudrun ^a   Rajanayagam, Odelia ^b   Soos, Maria A ^a,b   George, Stella ^a,b   Berger, Dirk ^a,b   Thomas, E Louise ^d   Bell, Jimmy D ^d   Meeran, Karim ^d   Ross, Richard J ^e   Vidal Puig, Antonio ^a,b   Wareham, Nicholas J ^a   O’Rahilly, Stephen ^a,b   Chatterjee, V Krishna K ^b   Schafer, Alan J ^c   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Department of Life Sciences   (United States)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN SUBUNIT;

ADIPOCYTE; ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; FRAMESHIFT MUTATION; GENE INTERACTION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; INHERITANCE; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; CHO CELLS; CRICETINAE; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; FRAMESHIFT MUTATION; HETEROZYGOTE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PEDIGREE; PHOSPHOPROTEIN PHOSPHATASE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS;

EID: 18644382993     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng926     Document Type: Article

References (29)

1. Barroso, I. et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883 (1999).
2. Rosen, E.D. & Spiegelman, B.M. Pparγ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731-37734 (2001).
3. Mukherjee, R. et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386, 407-410 (1997).
4. Olefsky, J.M. Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J. Clin. Invest. 106, 467-472 (2000).
5. Yamauchi, T. et al. Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108, 1001-1013 (2001).
6. Kubota, N. et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 4, 597-609 (1999).
7. Miles, RD., Barak, Y., He, W., Evans, R.M. & Olefsky, J.M. Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. J. Clin. Invest. 105, 287-292 (2000).
8. Bjorntorp, P. and Sjostrom, L. Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism 27, 1853-1865 (1978).
9. Newgard, C.B., Brady, M.J., O'Doherty, R.M. & Saltiel, A.R. Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 49, 1967-1977 (2000).
10. Suzuki, Y., et al. Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific phosphatase PP1G/RGL. Mol. Cell. Biol. 21, 2683-2694 (2001).
11. Nielsen, J.N. et al. Glycogen synthase localization and activity in rat skeletal muscle is strongly dependent on glycogen content. J. Physiol. 531, 757-769 (2001).
12. Burghes, A.H., Vaessin, H.E. & de La Chapelle, A. Genetics. The land between Mendelian and multifactorial inheritance. Science 293, 2213-2214 (2001).
13. Bruning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561-572 (1997).
14. Birnbaum, M.J. Diabetes. Dialogue between muscle and fat. Nature 409, 672-673 (2001).
15. Abel, E.D. et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733 (2001).
16. Steppan, C.M. & Lazar, M.A. Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13, 18-23 (2002).
17. Kelley, D.E. & Goodpaster, B.H. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24, 933-941 (2001).
18. McGarry, J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258, 766-770 (1992).
19. Zhang, L. et al. Whole genome amplification from a single cell: implications for genetic analysis. Proc. Natl Acad. Sci. USA 89, 5847-5851 (1992).
20. Thorpe, K.L., Schafer, A.J., Genin, E., Trowsdale, J. & Beck, S. Detection of polymorphism in the RING3 gene by high-throughput fluorescent S5CP analysis. Immunogenetics 49, 256-265 (1999).
21. Collingwood, T.N., Adams, M., Tone, Y. & Chatterjee, V.K. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol. Endocrinol. 8, 1262-1277 (1994).
22. Zamir, I., Zhang, J. & Lazar, M.A. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11, 835-846 (1997).
23. Forman, B.M. et al. 15-Deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812 (1995).
24. Rasmussen, S.K. et al. Adenovirus-mediated expression of a naturally occurring Asp905Tyr variant of the glycogen-associated regulatory subunit of protein phosphatase-1 in L6 myotubes. Diabetologia 43, 718-722 (2000).
25. Rico-Sanz, J. et al. Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS. J. Appl. Physiol. 87, 2068-2072 (1999).
26. Tang, P.M., Bondor, J.A., Swiderek, K.M. & DePaoli-Roach, A.A. Molecular cloning and expression of the regulatory (RGI) subunit of the glycogen-associated protein phosphatase. J. Biol. Chem. 266, 15782-15789 (1991).
27. Thomas, E.L. et al. Magnetic resonance imaging of total body fat. J. Appl. Physiol. 85, 1778-1785 (1998).
28. Black, D. et al. Obesity. A report of the Royal College of Physicians. J. R. Coll. Physicians Lond. 17, 5-65 (1983).
29. Matthews, D.R. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).